🚀 VC round data is live in beta, check it out!
Curaleaf Valuation Multiples
Discover revenue and EBITDA valuation multiples for Curaleaf and similar public comparables like Green Thumb Industries, Trulieve Cannabis, Cronos Group, Tilray Brands and more.
Curaleaf Overview
About Curaleaf
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
Founded
2014
HQ
Employees
5.5K
Website
Financials (LTM)
EV
$3B
Curaleaf Financials
Curaleaf reported last 12-month revenue of $1B and EBITDA of $277M.
In the same LTM period, Curaleaf generated $635M in gross profit, $277M in EBITDA, and had net loss of ($227M).
Revenue (LTM)
Curaleaf P&L
In the most recent fiscal year, Curaleaf reported revenue of $1B and EBITDA of $275M.
Curaleaf expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $635M | XXX | $631M | XXX | XXX | XXX |
| Gross Margin | 49% | XXX | 50% | XXX | XXX | XXX |
| EBITDA | $277M | XXX | $275M | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 22% | XXX | XXX | XXX |
| EBIT Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| Net Profit | ($227M) | XXX | ($231M) | XXX | XXX | XXX |
| Net Margin | (18%) | XXX | (18%) | XXX | XXX | XXX |
| Net Debt | — | — | $459M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Curaleaf Stock Performance
Curaleaf has current market cap of $2B, and enterprise value of $3B.
Market Cap Evolution
Curaleaf's stock price is $2.73.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $2B | 0.2% | XXX | XXX | XXX | $-0.30 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCuraleaf Valuation Multiples
Curaleaf trades at 2.2x EV/Revenue multiple, and 10.3x EV/EBITDA.
EV / Revenue (LTM)
Curaleaf Financial Valuation Multiples
As of April 19, 2026, Curaleaf has market cap of $2B and EV of $3B.
Equity research analysts estimate Curaleaf's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Curaleaf has a P/E ratio of (9.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 2.2x | XXX | 2.2x | XXX | XXX | XXX |
| EV/EBITDA | 10.3x | XXX | 10.4x | XXX | XXX | XXX |
| EV/EBIT | 129.8x | XXX | 112.1x | XXX | XXX | XXX |
| EV/Gross Profit | 4.5x | XXX | 4.5x | XXX | XXX | XXX |
| P/E | (9.3x) | XXX | (9.2x) | XXX | XXX | XXX |
| EV/FCF | 51.2x | XXX | 39.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Curaleaf Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Curaleaf Margins & Growth Rates
Curaleaf's revenue in the last 12 month grew by 6%.
Curaleaf's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Curaleaf's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Curaleaf's rule of X is 34% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Curaleaf Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 22% | XXX | XXX | XXX |
| EBITDA Growth | 6% | XXX | 2% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 26% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 34% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 34% | XXX | 34% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 48% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Curaleaf Public Comps
See public comps and valuation multiples for other Cannabis comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Curaleaf | XXX | XXX | XXX | XXX | XXX | XXX |
| Green Thumb Industries | XXX | XXX | XXX | XXX | XXX | XXX |
| Trulieve Cannabis | XXX | XXX | XXX | XXX | XXX | XXX |
| Cronos Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Tilray Brands | XXX | XXX | XXX | XXX | XXX | XXX |
| Glass House Brands | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Curaleaf M&A Activity
Curaleaf acquired XXX companies to date.
Last acquisition by Curaleaf was on XXXXXXXX, XXXXX. Curaleaf acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Curaleaf
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCuraleaf Investment Activity
Curaleaf invested in XXX companies to date.
Curaleaf made its latest investment on XXXXXXXX, XXXXX. Curaleaf invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Curaleaf
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Curaleaf
| When was Curaleaf founded? | Curaleaf was founded in 2014. |
| Where is Curaleaf headquartered? | Curaleaf is headquartered in United States. |
| How many employees does Curaleaf have? | As of today, Curaleaf has over 5K employees. |
| Who is the CEO of Curaleaf? | Curaleaf's CEO is Boris Jordan. |
| Is Curaleaf publicly listed? | Yes, Curaleaf is a public company listed on OTC Pink Sheets. |
| What is the stock symbol of Curaleaf? | Curaleaf trades under CURLF ticker. |
| When did Curaleaf go public? | Curaleaf went public in 2018. |
| Who are competitors of Curaleaf? | Curaleaf main competitors are Green Thumb Industries, Trulieve Cannabis, Cronos Group, Tilray Brands. |
| What is the current market cap of Curaleaf? | Curaleaf's current market cap is $2B. |
| What is the current revenue of Curaleaf? | Curaleaf's last 12 months revenue is $1B. |
| What is the current revenue growth of Curaleaf? | Curaleaf revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Curaleaf? | Current revenue multiple of Curaleaf is 2.2x. |
| Is Curaleaf profitable? | Yes, Curaleaf is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Curaleaf? | Curaleaf's last 12 months EBITDA is $277M. |
| What is Curaleaf's EBITDA margin? | Curaleaf's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Curaleaf? | Current EBITDA multiple of Curaleaf is 10.3x. |
| What is the current FCF of Curaleaf? | Curaleaf's last 12 months FCF is $56M. |
| What is Curaleaf's FCF margin? | Curaleaf's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Curaleaf? | Current FCF multiple of Curaleaf is 51.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.